Nadia Khan MD
Assistant Professor Hematology - Oncology
Fox Chase Cancer Center
Dr. Nadia Khan is an assistant professor of medical oncology and faculty member at Fox Chase Cancer Center and specializes in the treatment of patients with CLL, and B cell Malignancies. She completed her medical residency and medical school education at Temple University in Philadelphia.
Her research focus is the development of clinical trials that utilize novel therapies for CLL and lymphomas and the development of therapeutic paradigms that co-opt the immune system. Dr. Khan serves as a committee member of the NCCN CLL and B-Cell Lymphoma panels, as well as ECOG-lymphoma and the Lymphoma Consortium. Dr. Khan is currently the PI for a number of both investigator-initiated and industry-sponsored trials in CLL and B cell malignancies.